Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2026 Results

About this update from Covalon Technologies Ltd.

Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2026 Results .bwalignc { text-align: center; list-style-position: inside } Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q2 Fiscal 2026 results on Thursday, May 21, 2026, before markets open. A conference call and webcast to discuss the results will be held on Thursday, May 21, 2026, at 8:30am ET. To view, listen to, and participate in the live webcast, please follow the link below: https://events.q4inc.com/attendee/485973962 To listen and participate via the conference call, please dial: USA Toll-Free: 1-800-715-9871 Canada Toll-Free: 1-800-715-9871 Local (Toronto): 647-932-3411 Conference ID: 4934172 Participants will be able to ask questions during the Q&A portion of the conference call either by asking them on the call or by submitting them using the chat function on the webcast. A recording of the call will be available on www.covalon.com under News & Events on the Investors tab. Copies of Covalon’s financial statements and MD&A can be obtained on SEDAR PLUS at www.sedarplus.ca and under SEDAR Filings on the Investors tab of Covalon’s website. Those interested in learning about Covalon’s solutions may visit www.covalon.com or follow Covalon on LinkedIn , Facebook , Instagram , or X . About Covalon Covalon is a leading MedTech company dedicated to improving patient outcomes through innovative and compassionate medical products and technologies. Our expertise spans advanced wound care, vascular access, and surgical consumables, with a strong focus on enhancing healing, reducing healthcare-associated infections (HAIs), and protecting skin integrity. Our solutions are designed for patients and made for care providers. The Company is listed on the TSX Venture Exchange (COV) and trades on the OTCQX Market (CVALF). To learn more about Covalon, visit our website at www.covalon.com . Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release may contain forward-looking statements which reflect the Company's current expectations regarding future events. The forward-looking statements are often, but not a...

View stock analysis, news, and events for Covalon Technologies Ltd.